What the immune response to the coronavirus says about the prospects for a vaccine.

@article{Ledford2020WhatTI,
  title={What the immune response to the coronavirus says about the prospects for a vaccine.},
  author={Heidi Ledford},
  journal={Nature},
  year={2020}
}
  • Heidi Ledford
  • Published 17 August 2020
  • Medicine, Political Science
  • Nature
Viral immunologists say that results so far have been predictable — here’s why that’s good news. Viral immunologists say that results so far have been predictable — here’s why that’s good news. 
Decorated and Encapsulated: Virus-Like Particles Against Viral Infections
Despite great progress in the field of vaccine development, outbreaks of emerging pathogens and insufficient immunogenicity of some licensed vaccines call for the development of novel technologies inExpand
Understanding COVID-19 vaccines and immunity
COVID-19 Vaccines are currently the talk of the world The internet is full of memes on COVID-19 vaccines - myths more than truths In this commentary we further review some of the issues related toExpand
Current updates on adaptive immune response by B cell and T cell stimulation and therapeutic strategies for novel coronavirus disease 2019 (COVID-19) treatment
TLDR
This review summarizes the information from occurrence of SARS-CoV-2 to its pathogenesis, transmission, adaptive immune response with respect to T cell and B cell stimulation and therapeutic interventions/treatment against COVID-19. Expand
V483A: an emerging mutation hotspot of SARS-CoV-2
TLDR
This review compares the wild-type and the V483A mutants to analyze certain factors like the interaction between the virus and host-cell interface, binding affinity, stability, partition energy, hydrophobicity, occurrence rate and transmissibility. Expand
Emerging Patent Landscape for Gene Therapy as a Potential Cure for COVID-19
TLDR
An analysis of the emerging patent landscape was given on gene therapies for coronavirus under development, highlighting patent applications' basic status, geographical distribution, time-series analysis of new inventors, and ranking of patent applicants. Expand
V483a – an Emerging Mutation Hotspot of Sars-Cov-2
TLDR
This review compares the wild-type and the V483A mutants to analyze certain factors like the interaction between the virus and host-cell interface, binding affinity, stability, partition energy, hydrophobicity, occurrence rate and transmissibility. Expand
COVID-19 and Future Disease X in Circular Economy Transition: Redesigning Pandemic Preparedness to Prevent a Global Disaster
TLDR
Evidence provided here indicates that this novel preventive-based and resource-saving preparedness system could contribute to reverse the detrimental impacts of the pandemic on global economy and increase its resilience, and propose a pro-active global eco-social pandemic preparednessSystem. Expand
Experiencia y manejo de la COVID-19 en Lima Norte
This paper shows the experience lived in the Direccion de Redes Integradas de Lima Norte (DIRIS Lima Norte) in the face of the COVID-19 pandemic, where it was tackled ingeniously and boldly, withExpand
Our Identity Remains Marked!
TLDR
The purpose of this article is to collectively work towards understanding and resolving the COVID-19 pandemic issues based on Messersmith's (2018) song, The authors All Do Better When They All do Better, to understand and overcome the workings of a virus whose Identity [DOES NOT] Remain Marked. Expand

References

SHOWING 1-9 OF 9 REFERENCES
Pre-existing immunity to SARS-CoV-2: the knowns and unknowns
TLDR
The potential implications of T cell reactivity against SARS-CoV-2 in unexposed people, Crotty and Sette discuss, for disease severity, herd immunity and vaccine development. Expand
Selective and cross-reactive SARS-CoV-2 T cell epitopes in unexposed humans
TLDR
A range of preexisting memory CD4+ T cells that are cross-reactive with comparable affinity to SARS-CoV-2 and the common cold coronaviruses human coronavirus (HCoV)-OC43, H coV-229E, H CoV-NL63, and HCov-HKU1 are demonstrated. Expand
The time course of the immune response to experimental coronavirus infection of man.
TLDR
After preliminary trials, the detailed changes in the concentration of specific circulating and local antibodies were followed in 15 volunteers inoculated with coronavirus 229E and they appeared to show some resistance to disease and in the extent of infection. Expand
SARS-CoV-2-specific T cell immunity in cases of COVID-19 and SARS, and uninfected controls
TLDR
Infection with betacoronaviruses induces multi-specific and long-lasting T cell immunity against the structural N protein, and SARS-CoV-2-reactive T cells were found in individuals who had recovered from SARS or COVID-19 and in unexposed donors, although with different patterns of immunoreactivity. Expand
Functional SARS-CoV-2-specific immune memory persists after mild COVID-19
TLDR
It is demonstrated that mild COVID-19 elicits memory lymphocytes that persist and display functional hallmarks associated with antiviral protective immunity. Expand
Neutralizing antibody responses to SARS-CoV-2 in a COVID-19 recovered patient cohort and their implications
TLDR
The variations of SARS-CoV-2 specific NAbs in recovered COVID-19 patients may raise the concern about the role of NAbs on disease progression and the correlation of NAb titers with age, lymphocyte counts, and blood CRP levels suggested that the interplay between virus and host immune response in coronavirus infections should be further explored. Expand
Longitudinal evaluation and decline of antibody responses in SARS-CoV-2 infection
TLDR
It is suggested that this transient nAb response is a feature shared by both a SARS-CoV-2 infection that causes low disease severity and the circulating seasonal coronaviruses that are associated with common colds. Expand
Broadly neutralizing antibodies in HIV-1 treatment and prevention
TLDR
Although in very early stages, bnAbs capable of neutralizing a broad range of inter- and intraclade HIV-1 isolates have been demonstrated to have potential in treating patients, they are proposed to be advantageous over the latter as far as durability and side effects are concerned. Expand
Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections
TLDR
A cohort of asymptomatic patients infected with SARS-CoV-2 had significantly lower levels of virus-specific IgG antibodies compared to a cohort of age- and sex-matched symptomatic infected patients. Expand